PURPOSE STATEMENT
The purpose of our postgraduate year one (PGY1) residency program is to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in pharmacy practice. These programs will build upon Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
The purpose of our PGY2 programs is to build upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Residents will have the opportunity to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. Upon completion of this program, the resident should possess the competencies that enable attainment of board certification and qualify for a career path in their respective specialty area.
Our Department of Pharmacy Services supports the goals of our residency programs. The Department of Pharmacy Services is a dynamic department with a progressive clinical focus, staffed by sixteen pharmacists, eight pharmacy residents, six interns, eight clinical coordinators, three clinical pharmacy educators, technicians, messengers, and a dedicated management team. The department participates in all aspects of medication safety and dispensing with state of the art computer systems and technology. Dispensing services are achieved with a balance of professional, technical, and automated services, including a complete intravenous admixture service, TPN compounder, and robotics.
Pharmacy Residency Program (PGY-1) |
Pharmacy Residency Program (PGY-2) Ambulatory Care |
|
The PGY-1 Pharmacy Residency experience is intended to prepare the graduate to function as a Pharmacotherapist within the typical health-system. These experiential rotations will include:
^All residents participate in an Ambulatory Care experience to develop direct patient care skills. Collaborative Disease State Management Clinics include: Anticoagulation; Asthma (Adult/Pediatric); Heart Failure; Immunizations; Diabetes; Primary Care HIV; Smoking Cessation; HIV Patient Counseling; Medical Home; Pediatric Endocrine; Hepatitis C 
|
The Ambulatory Care Pharmacy Residents (PGY-2) will have a strong emphasis in outpatient disease management clinics. Ten months will be spent in the outpatient setting.
Collaborative Disease State Management Clinics include:
As a component of the experience, the resident will have inpatient experience with a 4-week internal medicine rotation, 4-week Transitions of Care rotation (elective), and participating in the in-house on-call program. Residents will have the opportunity to respond to cardiac arrest, pediatric emergencies, and rapid responses, as well as to provide drug information, toxicology consultation, and pharmacokinetic dosing consults within the institution. Ambulatory Care PGY2's do not typically stay 24 hrs in-house; rather their on-call experience is limited to a day shift approximately once every 2-3 weeks after an initial overnight orientation period. A third Ambulatory Care PGY-2 residency position is offered at TBHC through Long Island University (see below). |
Combined Pharmacy Residency (PGY2)/Fellowship Program in Infectious Diseases
The Infectious Diseases Pharmacy Residency (PGY2)/Fellowship provides an environment of quality training in inpatient and outpatient infectious diseases pharmacotherapy, teaching, academia, and research. Successful completion of the program prepares the individual to pursue career opportunities as a clinical specialist or faculty member at a college of pharmacy.
YEAR 1 (PGY2 residency)
The PGY2 ID residency develops proficiency in infectious diseases pharmacotherapy and practice management in both the inpatient and outpatient settings.
The following learning experiences are available throughout the PGY2 year:
As a component of the inpatient experience, the resident will be responsible for responding to cardiac arrest, pediatric emergencies, as well as to provide drug information, toxicology consultation, pharmacokinetic dosing consults within the institution as part of the program’s in-house on-call program. This will require the resident to remain in the hospital for a 24-hour period approximately once every 2-3 weeks, as well as a day shift every 3 weeks.
YEAR 2 (Fellowship)
The ID fellowship follows successful completion of the PGY2 ID residency program. The fellowship program is sponsored through the Arnold & Marie Schwartz College of Pharmacy and Health Sciences (LIU Pharmacy).
Goals of the fellowship component include:
YEAR 1 (PGY2 residency)
The PGY2 ID residency develops proficiency in infectious diseases pharmacotherapy and practice management in both the inpatient and outpatient settings.
The following learning experiences are available throughout the PGY2 year:
- Foundations of Microbiology
- Antimicrobial Stewardship (longitudinal)
- Adult Inpatient ID Consult Service
- Pediatric Inpatient ID
- Critical Care
- Emergency Medicine Antimicrobial Stewardship
- ID in Immunocompromised Patients
- HIV Clinic (longitudinal)
- Research
As a component of the inpatient experience, the resident will be responsible for responding to cardiac arrest, pediatric emergencies, as well as to provide drug information, toxicology consultation, pharmacokinetic dosing consults within the institution as part of the program’s in-house on-call program. This will require the resident to remain in the hospital for a 24-hour period approximately once every 2-3 weeks, as well as a day shift every 3 weeks.
YEAR 2 (Fellowship)
The ID fellowship follows successful completion of the PGY2 ID residency program. The fellowship program is sponsored through the Arnold & Marie Schwartz College of Pharmacy and Health Sciences (LIU Pharmacy).
Goals of the fellowship component include:
- Build upon the knowledge and experience acquired during PGY2 ID residency to provide evidence-based pharmacotherapy to diverse patient populations with infectious diseases
- Develop skills and experience in research protocol development, data collection and analysis, and abstract and peer-reviewed manuscript writing
- Function as a productive member of the interdisciplinary infectious diseases team and antibiotic stewardship program
- Critically evaluate medical literature and apply the information to optimize patient care
- Clinical practice rotations (9 months)
- Adult Inpatient ID Consult Service (6 months)
- Antimicrobial Stewardship (3 months)
- Clinical practice (longitudinal)
- Precept pharmacy residents through the 24-hour Pharmacotherapy On-call Program
- Research (longitudinal)
- Research conducted during the fellowship can be tailored towards the interests of the fellow (e.g. clinical, in vitro, translational, etc.)
- Serve as a co-investigator for PGY1 and PGY2 ID-related research projects
- Submission of research to infectious diseases conferences for poster or platform presentations
- Preparation of manuscript suitable for publication in peer-reviewed journals
- Teaching and Academia (longitudinal)
- Present at TBHC Pharmacotherapy Grand Rounds
- Teach one or more didactic lectures at LIU
- Participate in pharmacy resident orientation of ID-related services
- Precept pharmacy residents and students on ASP or ID consult rotations
- The fellow will serve as a mentor to the PGY2 ID pharmacy resident
- Discovery of optimal antimicrobial regimens for infections caused by multidrug-resistant (MDR) bacteria, including, carbapenem-resistant enterobacteriaceae (CRE), Pseudomonas aeruginosa, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus
- Identification of optimal beta-lactam pharmacodynamics/pharmacokinetic (PKPD) targets against MDR bacteria through in vitro and in silico modeling
- Clinical translation of in vitro PKPD findings to advance therapeutic drug monitoring practices
These programs are a joint collaboration between LIU Pharmacy and The Brooklyn Hospital Center. The residency experience is designed to develop the resident into an independent practitioner with advanced expertise and an engaged faculty member with exposure to the three-legged stool of academia: teaching, service, scholarship.
Pharmacy Residency Program (PGY-2)
|
Pharmacy Residency Program (PGY-2)
|
Fellowship in Interdisciplinary Telehealth for Medically Underserved Patients
Long Island University (LIU) and The Brooklyn Hospital Center (TBHC) are geographic neighbors and maintain a longstanding master affiliation agreement that enables LIU faculty and students to provide clinical care to TBHC’s patients in an experiential education model. Currently, five advanced practice pharmacists are permanently stationed at TBHC, with three in the Ambulatory Care Center. In addition, nursing and allied health faculty visit TBHC to participate in the clinical practicum of their respective students. Students and faculty participate in a very successful interdisciplinary clinic model for HIV(+) patients in the hospital’s PATH Center. They also manage a large number of cardiology patients in several collaborative drug therapy management clinics.
Recent data, collected during the COVID-19 pandemic, demonstrated that faculty clinicians, with student involvement, were able to convert outpatient services to a rudimentary Telehealth model with similar patient outcomes to the pre-COVID-19 period. Although half of the patient visits during the COVID time period were performed via Telehealth, clinic outcomes remained stable when compared to the three months in the pre-COVID period. This highlights the success of the model, but also the need for a more reliable model, technically equipped and with provider expertise. In addition, these Telehealth visits were conducted solely by advanced practice pharmacists who noted that many patients had nursing and psychosocial/behavioral health needs that were not being adequately met during the Telehealth period. In some cases, eligible patients were referred to outside home-health/“wrap around” agencies. This fellowship will develop a more robust interdisciplinary model for these patients.
To accomplish this, LIU will deploy the two healthcare fellows (one nurse and one pharmacist) to collaborate and supervise a team of health professional students in a Telehealth clinic for patients with cardiovascular-related conditions.
Nursing fellows will be licensed nurses who are trained at an advanced practice level as a Nurse Practitioner and have completed a doctorate level degree (DNP). They are qualified to diagnose and treat patients and have training in behavioral health and social determinants, in addition to their clinical knowledge and skills. Pharmacy fellows will be licensed pharmacists who hold a doctoral degree (PharmD) with an additional two years of post-graduate residency training. Pharmacy fellows will have post-graduate residency training specifically in ambulatory care with experience in collaborative drug therapy management (CDTM) clinics.
In addition to the clinical benefit of having these highly trained nurses and pharmacists pooling their knowledge and skills in managing patients, this model will also generate much needed research and scholarship in both telehealth, as well as interdisciplinary care models. The fellows will supervise and train approximately 30 students per year in this model, managing approximately 500 Telehealth patient encounters, with the expectation that these students will enter the healthcare workforce with the skills and experience to continue this model.
Telehealth will be targeted to treat episodic care, like influenza during the high periods of the fall, or chronic disease state management as is done in various collaborative drug therapy management clinics by pharmacists who assess, monitor, and prescribe adjustments to medications. NPs diagnose and prescribe follow-up care plans. NP’s integrate all aspects of a patient’s health coordinating the healthcare team (PA, PT, OT, Social Work, and Communication).
Recent data, collected during the COVID-19 pandemic, demonstrated that faculty clinicians, with student involvement, were able to convert outpatient services to a rudimentary Telehealth model with similar patient outcomes to the pre-COVID-19 period. Although half of the patient visits during the COVID time period were performed via Telehealth, clinic outcomes remained stable when compared to the three months in the pre-COVID period. This highlights the success of the model, but also the need for a more reliable model, technically equipped and with provider expertise. In addition, these Telehealth visits were conducted solely by advanced practice pharmacists who noted that many patients had nursing and psychosocial/behavioral health needs that were not being adequately met during the Telehealth period. In some cases, eligible patients were referred to outside home-health/“wrap around” agencies. This fellowship will develop a more robust interdisciplinary model for these patients.
To accomplish this, LIU will deploy the two healthcare fellows (one nurse and one pharmacist) to collaborate and supervise a team of health professional students in a Telehealth clinic for patients with cardiovascular-related conditions.
Nursing fellows will be licensed nurses who are trained at an advanced practice level as a Nurse Practitioner and have completed a doctorate level degree (DNP). They are qualified to diagnose and treat patients and have training in behavioral health and social determinants, in addition to their clinical knowledge and skills. Pharmacy fellows will be licensed pharmacists who hold a doctoral degree (PharmD) with an additional two years of post-graduate residency training. Pharmacy fellows will have post-graduate residency training specifically in ambulatory care with experience in collaborative drug therapy management (CDTM) clinics.
In addition to the clinical benefit of having these highly trained nurses and pharmacists pooling their knowledge and skills in managing patients, this model will also generate much needed research and scholarship in both telehealth, as well as interdisciplinary care models. The fellows will supervise and train approximately 30 students per year in this model, managing approximately 500 Telehealth patient encounters, with the expectation that these students will enter the healthcare workforce with the skills and experience to continue this model.
Telehealth will be targeted to treat episodic care, like influenza during the high periods of the fall, or chronic disease state management as is done in various collaborative drug therapy management clinics by pharmacists who assess, monitor, and prescribe adjustments to medications. NPs diagnose and prescribe follow-up care plans. NP’s integrate all aspects of a patient’s health coordinating the healthcare team (PA, PT, OT, Social Work, and Communication).
Our PGY-1, PGY-2 Ambulatory Care, PGY-2 Emergency Medicine and PGY-2 Infectious Diseases Programs are all fully accredited by ASHP.